1. Biotherapy of chronic myelogenous leukemia

   • W. E. Aulitzky
   • C. Peschel
   • C. Huber

   Review Article Pages: 113 - 120

2. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML — A comparative morphometric study on sequential trephine biopsies

   • J. Thiele
   • H. M. Kvasnicka
   • R. Fischer

   Original Article Pages: 121 - 128

3. P53 Tumor suppressor gene in chronic myelogenous leukemia: A sequential study

   • A. Rovira
   • A. Urbano-Ispizua
   • C. Rozman

   Original Article Pages: 129 - 133

4. Pulmonary fungal infections in patients with hematological malignancies — Diagnostic approaches

   • M. von Eiff
   • M. Zühlsdorf
   • J. van de Loo

   Original Article Pages: 135 - 141

5. Risks of rhG-CSF treatment in drug-induced agranulocytosis

   • H. Demuynck
   • P. Zachée
   • M. A. Boogaerts

   Original Article Pages: 143 - 147

6. Presenting signs and symptoms in multiple myeloma: High percentages of stage III among patients without apparent myeloma-associated symptoms

   • F. Ong
   • J. Hermans
   • J. C. Kluin-Nelemans

   Original Article Pages: 149 - 152

7. Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia

   • E. Weidmann
   • J. Brieger
   • P. S. Mitrou

   Original Article Pages: 153 - 158

8. Molecular identification of hereditary persistence of fetal hemoglobin type 2 (HPFH type 2) in patients from Brazil

   • M. S. Gonçalves
   • S. Fahel
   • F. F. Costa

   Original Article Pages: 159 - 161

9. Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blasts

   • N. Yokose
   • K. Ogata
   • T. Nomura

   Case Report Pages: 163 - 167

10. Erroneously low APC ratio in patients with lupus anticoagulant

    • M. E. Gschwandtner
    • K. Lechner
    • I. Pabinger

    Letter to the Editors Pages: 169 - 170